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Abstract: Two compounds from the hexane extract of seeds of Byrsonima crassifolia were isolated and their structures elucidated using extensive 
spectroscopic analyses. These compounds are derived from the new labdane diterpene Labda-17-(1) and the known antimicrobial Labda-8 (17)-(2). The 
present study was aimed to study  the effect antimicrobial of novel diterpene 1 against bacterial pathogens showed a moderate activity with MIC values  
18.79-70.12 µg/ml  and a MBC ranging between 250-1000 µg/ml  against all assayed microorganisms. 
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Resumen: Se aislaron dos compuestos del extracto de hexano de semillas de Byrsonima crassifolia y sus estructuras se dilucidaron por medio de  extensos 
análisis espectroscópicos. Estos compuestos derivados del labdano corresponden al nuevo diterpeno Labda-17- (1) y el conocido antimicrobiano Labda-8(17)-
(2). En el presente estudio se estudió el efecto antimicrobiano del nuevo diterpeno 1 sobre algunas bacterias patógenas mostrando sobre de estas  una 
actividad moderada, con valores de MIC de  18.79-70.12 µg/ml y un rango de  MBC que oscila entre 250-1000 µg/ml frente a todos los microorganismos 
ensayados. 
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INTRODUCTION 
Byrsonima crassifolia is a tropical tree, commonly 
known as “nanche”, distributed widely in México, 
Central and South America (Holmgren et al., 1990). 
Nanche fruit is edible and bright yellow when after 
ripened, it has sweet taste and slightly bitter taste. In 
México, nanche is consumed as juice, liquor, jelly and 
candy. Since prehispanic times it has been used as 
medicine, reports on ethnobotanical uses include: bark, 
to promote bleeding in females, to facilitate childbirth  
and snakebite treatment; aerial parts, used as diuretic, 
febrifuge, to expel placenta and for diarrhea treatment; 
fruit, used for fever treatment and to induce a pleasant 
dizziness; bark and branches, assist in tightening loose 
teeth and fish poison; and finally, seeds for dysentery, 
infections, wound healing and anti-inflammatory 
(Bejar and Malone, 1993). Phytochemical studies 
indicate that nanche plant contains esters (Alves and 
Franco, 2003), epicatechins (Geiss et al.,1995), 
glycolipids (Rastrelli et al.,1997). A pharmacological 
study of leaf and bark extracts displayed spasmogenic 
effects (Bejar and Malone, 1993). In another study, a 
chloroformic extract from bark showed anti-
inflammatory activity when evaluated by the Croton 
oil model (Silva et al., 2007). Furthermore, the 
antioxidant activity of extracts from leaves, fruits and 
bark has been determinate (Maldini et al., 2009). The 
ethyl-acetate extract of roots exhibited antibacterial 
activity (Martinez-Vazquez et al., 1999). Also, the 
aqueous extract of leaves inhibited some 
dermatophytes (Caceres et al., 1993). The ethanol 
extract of leaves showed trypanocidal activity against 
Leishmania mexicana promastigotes (Berger et al., 
1998). The hypoglycemic activity of hexane extract 
have previously been reported (Perez-Gutierrez et al., 
2010). Based on traditional uses of seeds from B. 
crassifolia and given the lack of scientific studies on 
its potential pharmacological properties, the aim of 
this study was to investigate the potential antibacterial 
activity of a new diterpene labdane from seed of B. 
crassifolia. 
 
MATERIALS AND METHODS 
General experimental procedures 
IR spectra were recorded on a Perkin-Elmer FTRI 
1720X. Optical rotations were measured by a Perkin-





CNMR spectra were taken at 
a Bruker DRX-300 NMR spectrometer, with UXNMR 
software package, was used for NMR experiments; 
chemical shifts are reported in δ (ppm), downfield 
relative to TMS as an internal standard. The NMR 
experiments were carried out using the conventional 
pulse sequences as described in the literature. 
HREIMS were measured on a JEOL HX 110 mass 
spectrometer. Precoated  TLC silica gel 60  F254  
aluminum  sheets  and  Sephadex  LH-20  from  
Sigma-Aldrich (St. Louis, USA) were  used. Column 
chromatography was carried on Silica gel 60 (230-400 
mesh, Merck Co. New Jersey (USA), solvents used as 
eluents from Fermont (California, USA). 
 
Plant material 
B. crassifolia L. belong to the Malpighiaceae family, 
fruit were collected in Morelos state and were 
taxonomically authenticated in the Herbarium of 
Escuela Nacional de Ciencias Biologicas, Instituto 
Politécnico Nacional. A voucher specimen of the plant 
is stored for reference (No. 8976). 
  
Extraction, isolation and characterization of the B. 
crassifolia diterpene derived 
Seeds was air dried and the ground (4 kg) was 
extracted twice with hexane for 3 h. The seeds extracts 
were combined and evaporated in vacuum to generate 
a residue (225 g). The resulting extract was loaded 
onto a silica gel column chromatography and eluted 
with petroleum ether-acetone-hexane 2:1:0.5 and 7 
fractions (F1-F-7) have been obtained. These fractions 
were then tested for antimicrobial activity. Active 
fractions were pooled together according to their 
similarities provides by thin layer chromatography 
analysis. The fraction F3 was the fraction that showed 
antimicrobial properties. F3 was subjected to silica gel 
column chromatography eluted with CHCl3-EtOAc 
(11:2) to produce five fractions (F3-1 to F3-5). The 
active fraction F3-4 was subjected to chromatographed 
over silica gel column using CH2Cl2-CHCl3 3:1.5 to 
yield four subfractions (F34-1 to F34-4). The F34-1 
fraction was further purified by preparative plate using 
petroleum ether-EtOAc 1:4 and visualized with UV at 
254 nm. Fraction F341-2 was separated by Sephadex 
LH-20 using a gradient of CHCl3–MeOH (from 10:1 
to 5:1) to yield 1 (80 mg) and 2 (67 mg).  
 
Compound 1:  
Yellowish oil; α   -21.4º (CHCl3, c 0.68); IR νmax 2924, 





, (calc, for C38H68O4, 588.9217); 
1
H NMR (CDCL3, 300 MHz) δ: 1.55 (m, H-1a), 1.76 
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(dd, J = 13.1, 3.4 Hz, H-1b), 1.46  (dd, J = 13.1, 3.4 
Hz, H-2a), 1.66 (m, H-2b), 1.22 (m, H-3a), 1.58 (m, 
H-3b), 1.34 (m, H-5), 1.70 (m, H-6), 1.33 (1H, m, 7a), 
1.39 (m, H-7b), 1.84 (m, H-8), 1.96 (m, H-9),  1.39 
(m,  H-11a), 1.59 (m,  H-11b),  2.16  (m, H-12a), 1.76  
(m, H-12b), 5.3 (t, J= 6.4 Hz, H-14), 3.74 ( 2H,d, J= 
7.2 Hz, H-15), 0.96 (3H, s,  H-16), 4.08 (2H,d, J= 2.8 
Hz, H-17),  1.17 (s, H-18), 1.18 (s, H-19), 0.75 (s, H-
20), 2.02 (s, COOMe), 2.04, (s, COOMe), 1.18-1.25 
(CH2); 
13
C NMR (CDCL3, 100 MHz) δ: 33.21 (C-1), 
18.23 (C-2), 34.65 (C-3), 41.64 (C-4),  52.24 (C-5), 
25.71 (C-6), 39.89 (C-7),  37.82 (C-8), 54.32 (C-9), 
36.81 (C-10), 24.16 (C-11), 43.21 (C-12), 129.89 (C-
13), 131.18 (C-14), 68.72 (C-15), 16.52 (C-16), 62.54 
(C-17), 33.71 (C-18), 22.35 (C-19), 14.23 (C-20), 
172.13 (COOMe), 20.98 (COOMe), 173.07 (CH2-
COO-CH2). 
 
Screening for antibacterial activity  
Compound 1 was dissolved in DMSO at a final 
concentration of 10 mg/ml and serial dilutions were 
prepared using the same solvent which were 
aseptically dispensed onto sterilized 6 mm filter paper 
discs and dried. The disk-diffusion method (Gaydos, 
1982) was used to measure the antimicrobial activity 
of the compounds. The different organisms were 
seeded over previously sterilized Mueller-Hinton agar 
for bacteria. The zones of growth inhibition were 
observed around dried disks (Whatman 6 mm 
diameter). Each plate was inoculated with 0.1 ml of a 
bacterial culture directly from the 24 h broth culture 
diluted to match 0.5 MacFarland standard (108 Colony 
Forming Units (CFU)/ml). Inoculums on the plates 
were aseptically spread using a sterile glass rod to 
avoid contamination and allowed to stand for 2 - 3 
minutes in a refrigerator at 4° C. The discs loaded with 
1 were then placed onto the seeded plates. The 
bacterial cultures were incubated at 37° C for 24hr. 
After the incubation period, the zones of inhibition 
were measured and recorded in mm as described by 
Elgayyar et al., (2000). Negative controls were done 
by using sterile 6mm discs soaked in 10 ml of DMSO 
and dried.  
 
Minimum inhibitory concentrations (MIC) and 
minimum bactericidal concentrations (MBC) 
Compound  1  from  the  antibacterial  screening  was  
tested  for  Minimum Inhibitory Concentration (MIC) 
and  Minimum Bactericidal Concentration (MBC). 
The MIC was determined on 96-well microdilution 
plates   according the published protocols (Micheal et 
al., 2003). The MBC were determined by sub-
culturing 0.1 ml of all the tubes showing no growth on 
Nutrient Agar (NA). After 24 h incubation at 37° C, 
the first plate showing no growth was recorded as the 
MBC. The MICs accuracy was checked against 
standard antibiotics. Sterility of the media was 
controlled by use of broth only in a negative control 
tube, and growth of the organism was checked by 
broth plus microorganism in question in a positive 
control tube. All the controls were subjected to the 
same conditions as the tests. Antimicrobial sensitivity 
and resistance were confirmed by use of standard 
discs containing ciprofloxacin (10 µg/ml).  
 
RESULTS AND DISCUSSION 
Two compounds were isolated from hexane extract of 
seeds of B. crassifolia after purification through silica 
gel column chromatography. Compound 1 showed a 
molecular ion at m/z 588.9254 in its HREIMS and the 
presence of 38 carbons on the 
13
C NMR spectrum 
suggested a molecular formula C38H68O4, DEPT 
experiments classified the protonated carbon signals to 
six methyls, twenty three methylenes, four methines 
and five quaternary carbons. The   IR spectrum of 1 
showed absorption bands at νmax 1645 cm
-1
 to double 
bond and 1710 and 1163 cm
-1
 corresponding to an 
ester group, it was  supported by the presence of signal 
of quaternary carbons at δc 172.13 and δc 173.07 in its 
13
C NMR spectrum. Its 
1
H NMR spectrum showed 
signals for four tertiary methyl groups (δH 0.96, s; 
1.17, s; 1.18, s; 0.75, s), one trisubstituted double 
bonds (δH 5.3, t, J = 6.4 Hz) and two acetoxyl groups 
(δH 2.02, s and 2.04, s).  In the 
13
C NMR spectrum, 
two acetoxy carbonyl carbons (δC 172.13, and 173.07), 
and the one 129.89, trisubstituted double bonds 
characterized by the presence of the two olefinic 
carbons (δC and 131.18). Inspection  of  the 2D NMR 
data (
1
H–1H COSY, 1H–1H TOCSY, HSQC and 
HMBC) allowed the assignments of all the signals 
observed in the 1D NMR spectra and revealed the 
labdane skeleton of the diterpene 1 (Bohlmann and 
Czerson, 1979; Timmermann et al., 1986). 
Connectivities in the HMBC spectrum from H-17 to 
C-7, C-8 and C-9 (δC 54.32) corroborated the location 
of the side chain to be at C-9, whose methine proton 
H-9 (δH 1.96) formed an isolated proton spin system 
with H-11 (δH 1.39 and δH 1.59) and H-12 (δH 1.76 and 
2.16) as deduced from the COSY and TOCSY spectra 
(Itokawa et al.,1988). A trisubstituted double bond 
was located at C-13 (δC 129.89) and C-14 (δC 131.18) 
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Me-16 (δH 0.96) to C-12 (δC 43.21), C-13 and C-14, 
and from the olefinic proton H-14 (δH 5.3) to C-12 
(Figure 1). The double bond at C-13 was assigned as 
the E  configuration  because of the ROESY 
correlation observed between H-15 and Me-16, and by 
comparison of NMR data with those of related 
compounds (Urones et al., 1995; Su et al., 1996). 
Large number of methylene groups (22.7-34.4), 
suggesting the presence of fatty acid esterified with the 
labdane derivative at C-15. It is supported by the 
HMBC correlation between methylene protons H2-15 
(δH 4.08, 2H, d, J = 7.2 Hz) and methylene chain and 
the quaternary carbon δc 173.07. Analysis of 1H-1H 
COSY showed clear correlation between H5/H6, 
H6/H7, H11/H12 (Figure 2).  One methyl group 
(δc16.52), and large number of methylene groups (δc 
22.6-34.5) (DEPT) suggesting the presence of 
monoenic fatty acid esterified with a labdane 
derivative at C-15. The NMR data of the long-chain 
moiety were in good accordance with those for ∆9-
18:1 cis fatty acid esters (Mannina et al., 1999). 
Therefore, compound 1 was identified as labda-17-
acetoxi-13E-en-15-palmitate. All data of 
1






H, COSY and HMBC 
connectivities of 2 allowed the identification of labda-
8(17),13E-dien-19-carboxy-15-yl palmitate which was 
previously isolated from Cretan propolis (Peopova et 
al., 2009) exhibited a weak antimicrobial activity 
against Staphylococcus aureus, Staphylococcus 
epidermidis, Klebsiella pneumonia, Escherichia 
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Figure 1 
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Screening of the in vitro antimicrobial activity of 
diterpenoid 1 was studied against Gram positive 
microorganisms Bacillus cereus, Bacillus megaterium, 
Bacillus subtilis, Staphylococcus aureus, and Gram 
negative microorganisms as Escherichia coli, 
Salmonella paratyphi, Pseudomonus aeruginosa, 
Salmonella typhi, Shigella boydii, Salmonella 
dysenteriae, Vibrio mimicus and Vibrio 
parahemolyticus of significant importance using the 
filter paper disc agar diffusion technique. All the 
tested bacteria were standard strains from ATCC 
(American type culture collection). The results showed 
variations in the antimicrobial properties of diterpene 
labdane 1 (Table 1). Compound 1 had strong activity 
(inhibition zone ≥ 20 mm), moderate activity 
(inhibition zone < 20-12 mm) and no inhibition (zone 
< 12 mm). The most effective 1 was that of, S. 
paratyphi (23.87 ± 0.65 mm, zdi), followed by P. 
aeruginosa (21.45 ± 0.53 mm, zdi), S. typhi (20.72 ± 
0.56 mm, zdi), B. subtilis (20.89 ± 2.90 mm, zdi). In 
contrast, showed a moderate activity against B. 
megaterium (19.20 ± 3.42 mm, zdi), B.cereus (18.76 ± 
0.68), Staphylococcus aureus (17.95 ± 1.78), 
Escherichia coli (13.35 ± 1.43), and S. dysenteriae 
(16.52 ± 1.88). However, no signicant antimicrobial 
effect against Vibrio mimicus (12.08 ± 4.12), Sarcinia 
lutea (12.17 ± 1.23), V. parahemolyticus (11.87 ± 
4.20) and Shigella boydii (0.0 mm) was observed. 
Gram-positive bacterial cells were, in general, more 




 Antimicrobial activity of the compound 1 obtained  from seeds of Byrsonima crassifolia 
         Test microorganisms               Inhibition zone               MIC (µg/ml)                 MBC (µg/ml) 
                                                              diameter (mm) 
Gram positive bacteria  
Bacillus cereus ATCC 11778 
 
18.76 ± 0.68 
 
38.34 ± 1.87 
 
500 
B. megaterium ATCC 12872 19.20 ± 3.42 43.26 ± 2.76 500 
B. subtilis ATCC 6633 20.89 ± 2.90 41.28 ± 3.29 500 
Staphylococcus aureus ATCC 6538 17.95 ± 1.78 36.79 ± 1.87 500 
Sarcinia lutea ATCC 9341 12.17 ± 1.23 58.84 ± 4.76 1000 
Gram negative bacteria 
Escherichia coli ATCC 25922 
 
13.35 ± 1.43 
 
69.20 ± 2.76 
 
1000 
Pseudomonus aeruginosa ATCC 
9027 
21.45 ± 0.53 32.41 ± 4.11 500 
Salmonella paratyphi ATCC 6539 23.87 ± 0.65 20.27 ± 1.04 250 
S. typhi ATCC 43971 20.72 ± 0.56 18.79 ± 2.54 250 
Shigella boydii ATCC 9207 0.0 - - 
S. dysenteriae ATCC 13313 16.52 ± 1.88 45.67 ± 3.87 500 
Vibrio mimicus ATCC 33654 12.08 ± 4.12 66.78 ± 5.14 1000 
V. parahemolyticus ATCC 43996 11.87 ± 4.20 70.12 ± 4.98 1000 
Zone diameter inhibition (ZDI) of compound 1 (20 µg) per disk 
 
However, more precise data on antimicrobial 
properties were obtained through determinations of 
bacteriostatic and bactericidal concentrations. The 
minimun inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) the 
results are shown in Table 1. The most bacteriostatic 
properties was against all Gram-negative strains 
assayed. Martinez-Vazques et al., (1999) studied ethyl 
acetate, methanol extracts of roots and stems of B. 
crassifolia against Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Salmonella typhi, Shigella 
fiexneri, Staphylococcus aureus, Staphylococcus 
epididermis, Streptococcus pneumoniae and 
Micrococcus luteus. The ethyl acetate of roots was the 
most active.  In another research had been previously 
studied methanol extract from B. crassifolia against 
Staphylococcus aureus, Escherichia coli, 
Pseudomonas aeruginosa, and Candida albicans 
(Navarro et al., 1996). The results obtained by us 
indicate the existence of antimicrobial compounds in 
this plant, and show a good correlation between the 
reported studies of B. crassifolia uses in traditional 
medicine against infectious diseases and the 
experimental data of such extracts toward the most 
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common pathogens. Also results indicate the existence 
of antimicrobial compounds in the hexane extract of B. 
crassifolia, the phytochemical isolation and 
identification of two active compounds indicates that 
the antimicrobial activity of the seed of B.  crassifolia 
is due mainly to the presence of compounds  labdane 
diterpene. 
In conclusion the present study shows that 
antimicrobial activity is present in the seeds of B. 
crassifolia.  Bioassay with the purified diterpene 1 
indicated that exhibited strong activity against Gram 
negative bacterias. The results suggest that further 
investigations against other enteric Gram-positive and 
Gram-negative bacteria, which are frequently resistant 
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